Sun, Xiaoqi
Zhang, Yu
Li, Jiaqian
Park, Kyung Soo
Han, Kai
Zhou, Xingwu http://orcid.org/0000-0001-5977-2185
Xu, Yao
Nam, Jutaek http://orcid.org/0000-0002-0397-1449
Xu, Jin
Shi, Xiaoyue
Wei, Lei http://orcid.org/0000-0002-1881-8666
Lei, Yu Leo http://orcid.org/0000-0002-9868-9824
Moon, James J. http://orcid.org/0000-0003-2238-2372
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273, R01CA210273)
Article History
Received: 15 September 2020
Accepted: 23 July 2021
First Online: 30 September 2021
Competing interests
: A patent application (WO2020014644A1) for CMP-based metalloimmunotherapy has been filed, with J.J.M. and X. Sun as inventors. Y.L.L. has licensed the NOOC1 model to Kerafast Inc. (catalogue number: EMU061). The remaining authors declare no competing interests.